Cargando…
The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis
Acute kidney injury (AKI) is a prevalent pathological condition that is characterized by a precipitous decline in renal function. In recent years, a growing body of studies have demonstrated that renal maladaptation following AKI results in chronic kidney disease (CKD). Therefore, targeting the tran...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344918/ https://www.ncbi.nlm.nih.gov/pubmed/37443140 http://dx.doi.org/10.1038/s41419-023-05969-9 |
_version_ | 1785072968201666560 |
---|---|
author | Guo, Runzhi Duan, Jiayu Pan, Shaokang Cheng, Fei Qiao, Yingjin Feng, Qi Liu, Dongwei Liu, Zhangsuo |
author_facet | Guo, Runzhi Duan, Jiayu Pan, Shaokang Cheng, Fei Qiao, Yingjin Feng, Qi Liu, Dongwei Liu, Zhangsuo |
author_sort | Guo, Runzhi |
collection | PubMed |
description | Acute kidney injury (AKI) is a prevalent pathological condition that is characterized by a precipitous decline in renal function. In recent years, a growing body of studies have demonstrated that renal maladaptation following AKI results in chronic kidney disease (CKD). Therefore, targeting the transition of AKI to CKD displays excellent therapeutic potential. However, the mechanism of AKI to CKD is mediated by multifactor, and there is still a lack of effective treatments. Ferroptosis, a novel nonapoptotic form of cell death, is believed to have a role in the AKI to CKD progression. In this study, we retrospectively examined the history and characteristics of ferroptosis, summarized ferroptosis’s research progress in AKI and CKD, and discussed how ferroptosis participates in regulating the pathological mechanism in the progression of AKI to CKD. Furthermore, we highlighted the limitations of present research and projected the future evolution of ferroptosis. We hope this work will provide clues for further studies of ferroptosis in AKI to CKD and contribute to the study of effective therapeutic targets to prevent the progression of kidney diseases. [Image: see text] |
format | Online Article Text |
id | pubmed-10344918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-103449182023-07-15 The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis Guo, Runzhi Duan, Jiayu Pan, Shaokang Cheng, Fei Qiao, Yingjin Feng, Qi Liu, Dongwei Liu, Zhangsuo Cell Death Dis Review Article Acute kidney injury (AKI) is a prevalent pathological condition that is characterized by a precipitous decline in renal function. In recent years, a growing body of studies have demonstrated that renal maladaptation following AKI results in chronic kidney disease (CKD). Therefore, targeting the transition of AKI to CKD displays excellent therapeutic potential. However, the mechanism of AKI to CKD is mediated by multifactor, and there is still a lack of effective treatments. Ferroptosis, a novel nonapoptotic form of cell death, is believed to have a role in the AKI to CKD progression. In this study, we retrospectively examined the history and characteristics of ferroptosis, summarized ferroptosis’s research progress in AKI and CKD, and discussed how ferroptosis participates in regulating the pathological mechanism in the progression of AKI to CKD. Furthermore, we highlighted the limitations of present research and projected the future evolution of ferroptosis. We hope this work will provide clues for further studies of ferroptosis in AKI to CKD and contribute to the study of effective therapeutic targets to prevent the progression of kidney diseases. [Image: see text] Nature Publishing Group UK 2023-07-13 /pmc/articles/PMC10344918/ /pubmed/37443140 http://dx.doi.org/10.1038/s41419-023-05969-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Article Guo, Runzhi Duan, Jiayu Pan, Shaokang Cheng, Fei Qiao, Yingjin Feng, Qi Liu, Dongwei Liu, Zhangsuo The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis |
title | The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis |
title_full | The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis |
title_fullStr | The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis |
title_full_unstemmed | The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis |
title_short | The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis |
title_sort | road from aki to ckd: molecular mechanisms and therapeutic targets of ferroptosis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344918/ https://www.ncbi.nlm.nih.gov/pubmed/37443140 http://dx.doi.org/10.1038/s41419-023-05969-9 |
work_keys_str_mv | AT guorunzhi theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT duanjiayu theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT panshaokang theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT chengfei theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT qiaoyingjin theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT fengqi theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT liudongwei theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT liuzhangsuo theroadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT guorunzhi roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT duanjiayu roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT panshaokang roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT chengfei roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT qiaoyingjin roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT fengqi roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT liudongwei roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis AT liuzhangsuo roadfromakitockdmolecularmechanismsandtherapeutictargetsofferroptosis |